Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
September 30, 2026 42.15%
August 31, 2026 42.15%
July 31, 2026 42.15%
June 30, 2026 42.15%
May 31, 2026 42.15%
April 30, 2026 42.15%
March 31, 2026 42.15%
February 28, 2026 42.15%
January 31, 2026 42.15%
December 31, 2025 42.15%
November 30, 2025 42.15%
October 31, 2025 42.15%
September 30, 2025 42.15%
August 31, 2025 42.15%
July 31, 2025 42.15%
June 30, 2025 42.15%
May 31, 2025 42.15%
April 30, 2025 42.15%
March 31, 2025 42.15%
February 28, 2025 42.15%
January 31, 2025 42.15%
December 31, 2024 42.15%
November 30, 2024 42.15%
October 31, 2024 42.15%
September 30, 2024 42.15%
Date Value
August 31, 2024 42.15%
July 31, 2024 42.15%
June 30, 2024 42.15%
May 31, 2024 42.15%
April 30, 2024 42.15%
March 31, 2024 42.15%
February 29, 2024 40.80%
January 31, 2024 40.80%
December 31, 2023 40.80%
November 30, 2023 40.80%
October 31, 2023 39.16%
September 30, 2023 37.91%
August 31, 2023 36.18%
July 31, 2023 36.18%
June 30, 2023 36.18%
May 31, 2023 36.18%
April 30, 2023 36.18%
March 31, 2023 36.18%
February 28, 2023 34.25%
January 31, 2023 27.04%
December 31, 2022 27.04%
November 30, 2022 27.04%
October 31, 2022 27.04%
September 30, 2022 27.04%
August 31, 2022 27.04%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Novartis AG 20.42%
GSK Plc 39.39%
Merck & Co., Inc. 43.45%
AstraZeneca PLC 27.87%
Eli Lilly & Co. 34.47%